Their research and development facility is headquartered in Irvine, California and they currently carry 4 approved drugs for the hematology/oncology market. These products are Fusilev, Folotyn, Zevalin and Marqibo. Fusilev is their for injection drug that has already penetrated several European nations. They also have other drugs that are in late stages of development and several others that are in various phases of clinical trial. The company is committed to bringing products to the market, especially for the unmet medical areas in cancer treatment. Their expertise and pool of brilliant minds are focused on the development of drugs specific to oncology.
Spectrum has subsidiaries, including their operations in Canada (Spectrum Pharma Canada) and in Mumbai, India (OncoRx Pharma Pvt. Ltd). The people involved in the business are experts in either two things: development and marketing of oncology treatments or growing a profitable venture.